John Ormerod - 01 Jan 2026 Form 3 Insider Report for CONSTELLIUM SE (CSTM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
02 Jan 2026, 10:45:01 UTC
Next SEC filing
08 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kristine Carpenter, Attorney-in-Fact for John Ormerod

Key filing fact

John Ormerod filed Form 3 for CONSTELLIUM SE (CSTM) on 02 Jan 2026.

Key facts

  • This page summarizes John Ormerod's Form 3 filing for CONSTELLIUM SE (CSTM).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jan 2026, 10:45.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002092962 Primary reporting owner

Ormerod John

Relationship
Director
Address
300 EAST LOMBARD STREET, SUITE 1710, BALTIMORE
Signature
/s/ Kristine Carpenter, Attorney-in-Fact for John Ormerod
Signature date
02 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSTM holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
32,873
Date
01 Jan 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .